Doug Kelly

Partner
Alloy Ventures

Doug Kelly received a BA in Biochemistry and Molecular Biology from the University of California at San Diego, an M.D. from the Albert Einstein College of Medicine, and an MBA from Stanford. Prior to joining Alloy Ventures, he worked for two European venture capital firms, as well as for Ligand Pharmaceuticals, and as an independent consultant. He is currently a director of Favrille (NASDAQ: FVRL) and Pharsight (NASDAQ: PHST), both public companies, and several private companies including: Adiana, Arbor Surgical, BARRx, Crux Biomedical, KaloBios and Restoration Robotics. Doug also teaches a class at Stanford University, "Business 16; Financing The Start-up."